InvestorsHub Logo
Post# of 252235
Next 10
Followers 29
Posts 5148
Boards Moderated 0
Alias Born 05/24/2006

Re: biomaven0 post# 147962

Thursday, 08/30/2012 2:14:03 PM

Thursday, August 30, 2012 2:14:03 PM

Post# of 252235
On "solanezumab is not dead yet" issue

Agree on both your points - there is a small signal, probably not clinically significant but could be disease modifying.
I'm thinking: if the effect correlates with the biomarkers, it would be worth trying another trial perhaps in prodromal AD patients and negotiate with the FDA on using these biomarkers along with cognitive measure as efficacy endpoints.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.